Mike is Managing Director of the East Midlands Academic Health Science Network (AHSN) and Chair of the national AHSN network.
Mike joined the NHS from Thermo Fisher Scientific where he led the BioPharma Services Division in the United Kingdom as Vice President and General Manager supporting biopharmaceutical clients in the development of innovative, new medicines. Prior to joining Thermo Fisher, Mike worked for AstraZeneca where he most recently served as Vice President of Medicines Development leading scientists located in the United Kingdom and the United States. Earlier in his career, Mike led R&D and operational functions at Teva Pharmaceutical Industries, Ireland & India, Sanofi, UK and UCB, Germany.
Mike has led the development of formulations, devices, drug substance manufacturing processes and associated test methods for a number of innovative new medicines including Brilique, Caprelsa, Neupro, Pentacarinat, ProAir, QVAR EasiBreathe, Seroquel XR and Symbicort pMDI.
Mike received his DSc from De Montfort University, his MBA from the Open University, an MSc from the University of Brighton and is a pharmacy graduate of De Montfort University.
Mike is a visiting professor at De Montfort University and an honorary professor at the University of Leicester. He is a member of the Science & Research Advisory Panel of the Royal Pharmaceutical Society (RPS), the advisory board of the Academy of Pharmaceutical Science, the University of Bath pharmacy advisory group, the MediLink East Midlands board and the East Midlands NHS Clinical Senate.